Kyungdong Pharmaceutical Passes Post-Certification Audit for Anti-Corruption Management System 'ISO 37001'

[Asia Economy Reporter Hyunseok Yoo] Kyungdong Pharmaceutical announced on the 31st that it has passed the follow-up audit for maintaining the ‘ISO 37001 Anti-Bribery Management System’ from the global certification body Lloyd's Register.

The ‘ISO 37001 Anti-Bribery Management System’ is an international certification standard for anti-bribery management systems established and published by the International Organization for Standardization (ISO). It was established on October 14, 2016, based on the UK's anti-bribery standard (BS10500) and considering the requirements of the UN Convention against Corruption and the OECD Anti-Bribery Convention.

A Kyungdong Pharmaceutical official stated, “By introducing the anti-bribery management system, we identify internal and external corruption-related issues and stakeholders, and preemptively control and monitor corruption risks,” adding, “We will continue to establish the anti-bribery management system as a corporate culture and take the lead in building a transparent and ethical management system.”

Meanwhile, Kyungdong Pharmaceutical received the final ‘ISO 37001’ certification in 2019 through the results of the first-stage document review including internal audits and the second-stage on-site audit. Since obtaining the certification, it undergoes annual follow-up audits to ensure compliance with the ‘ISO 37001’ standard requirements for system operation maintenance and inspection. In the second year, a strict process including document review and employee interviews must be completed.

This content was produced with the assistance of AI translation services.